MILL VALLEY, Calif.--(BUSINESS WIRE)--BioCision LLC today released new data demonstrating that the company’s CoolCell® technology resulted in a 33 percent increase in human embryonic stem cell (hESC) viability when compared to common freezing methods, such as styrofoam boxes, paper towel wraps and alcohol-based methods.